Various molecules have been investigated in the context of bone neoplasms, especially in osteosarcoma (OS) and its variants and mimics, including the well-characterized oncogenes CDK4 and MDM2 and the tumor suppressor gene p53 (5-8). This evidence concerns the gene TP53 and osteosarcoma.